Cellular Therapies for Multiple Myeloma: A Paradigm Shift

John SchieszerJun 1, 2018Therapy with CAR T cells may benefit patients with highly refractory multiple myeloma, said U Penn ’s Adam Cohen at ASCO 2018.

Source: CancerNetwork - June 1, 2018 Category: Cancer & Oncology Authors: A Source Type: news